Concepedia

António Araújo

AA

34

Publications

4.2K

Citations

20

H-Index

2004

Active since

Affiliations

Universidade do Porto(Current)

Instituto Português de Oncologia Francisco Gentil

Centro Hospitalar do Porto

Portuguese League Against Epilepsy

IPO Porto

António Araújo is an author at Universidade do Porto specializing in medicine, oncology, and lung cancer.

ORCID

Top concepts

Publications per year

2004–2024

34

Publications

34

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.2K citations · Full text

Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study

Luis Paz‐Ares, Óscar Juan, Giannis Mountzios et al. · Journal of Clinical Oncology · 2024 · 91 citations · Full text

Circulating DNA: Diagnostic Tool and Predictive Marker for Overall Survival of NSCLC Patients

Raquel Catarino, Ana Coelho, António Araújo et al. · PLoS ONE · 2012 · 62 citations · Full text

A functional polymorphism in the promoter region of leptin gene increases susceptibility for non-small cell lung cancer

Ricardo Ribeiro, Ana Paula Araújo, Ana Coelho et al. · European Journal of Cancer · 2006 · 58 citations

, , +9

Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK –Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls

Daniel Shao-Weng Tan, António Araújo, Jie Zhang et al. · Journal of Thoracic Oncology · 2016 · 47 citations · Full text

Rows per page

1–5 of 34